Inventor · disambiguated record
Peter W. Schiller
Also filed as: SCHILLER PETER · SCHILLER PETER W
15 granted patents·13 pending applications·547 citations·filing 1989–2022
95Inventor score
Top patents by PatentIndex Score
28 records- 0197US7718620B2Methods for preventing or treating ischemia-reperfusion injury of the kidneyCORNELL RES FOUNDATION INC·Filed 2006·Granted May 18, 2010·57 cites·10 claims
- 0295US8957030B2Methods for preventing or treating mitochondrial permeability transitionCORNELL RES FOUNDATION INC·Filed 2013·Granted Feb 17, 2015·22 cites·12 claims
- 0395US7576061B2Methods for preventing mitochondrial permeability transitionCORNELL RES FOUNDATION INC·Filed 2004·Granted Aug 18, 2009·54 cites·45 claims
- 0495US6703483B1Compounds useful in pain managementCORNELL RES FOUNDATION INC·Filed 2000·Granted Mar 9, 2004·77 cites·9 claims
- 0593US7732398B2Medicinal uses of mu-opioid receptor agonistsCORNELL RES FOUNDATION INC·Filed 2006·Granted Jun 8, 2010·25 cites·11 claims
- 0692US7498297B2Medicinal uses of mu-opioid receptor agonistsCORNELL RES FOUNDATION INC·Filed 2001·Granted Mar 3, 2009·46 cites·4 claims
- 0792US5312899ADermorphin analogsIAF BIOCHEM INT·Filed 1989·Granted May 17, 1994·122 cites·5 claims
- 0889US8404646B2Methods for preventing or treating mitochondrial permeability transitionSCHILLER PETER W·Filed 2011·Granted Mar 26, 2013·15 cites·21 claims
- 0985US5602100ADermorphin analogs having pharmacological activityASTRA AB·Filed 1994·Granted Feb 11, 1997·73 cites·11 claims
- 1080US2023293624A1Methods for preventing or treating mitochondrial permeability transitionCORNELL RES FOUNDATION INC·Filed 2022·Application pending·0 cites
- 1170US2020038472A1Methods for preventing or treating mitochondrial permeability transitionCORNELL RES FOUNDATION INC·Filed 2019·Application pending·0 cites
- 1266US2019330272A1Aromatic-cationic peptides and uses of sameUNIV CORNELL·Filed 2018·Application pending·0 cites
- 1365US2015005242A1Aromatic-cationic peptides and uses of sameSZETO HAZEL H·Filed 2014·Application pending·0 cites
- 1464US5602099Aδ opioid receptor antagonistsASTRA AB·Filed 1994·Granted Feb 11, 1997·18 cites·10 claims
- 1563US2013316964A1Aromatic-cationic peptides and uses of sameSZETO HAZEL H·Filed 2013·Application pending·0 cites
- 1663US2018244721A1Aromatic-cationic peptides and uses of sameUNIV CORNELL·Filed 2017·Application pending·0 cites
- 1760US5455230ADelta opioid receptor antagonists and their use as analgesic agentsASTRA AB·Filed 1993·Granted Oct 3, 1995·16 cites·12 claims
- 1860US2004176305A1Novel compounds useful in pain managementASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 1958US2017008925A1Aromatic-cationic peptides and uses of sameSZETO HAZEL H·Filed 2016·Application pending·0 cites
- 2057US2015359838A1Methods for preventing or treating mitochondrial permeability transitionCORNELL RES FOUNDATION INC·Filed 2015·Application pending·0 cites
- 2157US2012329730A1Aromatic-cationic peptides and uses of sameSZETO HAZEL H·Filed 2011·Application pending·0 cites
- 2253US5811400APeptide derivatives with δ opioid receptor antagonist or mixed μ agδ antagonist effectsASTRA AB·Filed 1995·Granted Sep 22, 1998·10 cites·13 claims
- 2352US2010190718A1Methods for preventing or treating mitochondrial permeability transitionSCHILLER PETER W·Filed 2010·Application pending·0 cites
- 2451US5786447AOpioid peptide analogsASTRA AB·Filed 1995·Granted Jul 28, 1998·6 cites·14 claims
- 2543US2003032774A1Novel opioid peptides for the treatment of painASTRAZENECA AB·Filed 2001·Application pending·0 cites
- 2640US6150335ATic-containing opioid dipeptide derivatives useful as analgesicsASTRA AB·Filed 1997·Granted Nov 21, 2000·3 cites·4 claims
- 2739US5733881AOpioid peptide antagonistsASTRA AB·Filed 1995·Granted Mar 31, 1998·3 cites·15 claims
- 2835US2020308220A1Aromatic-cationic peptides conjugated to antioxidants and their use in treating complex regional pain syndromeSCHILLER PETER·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter W. Schiller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →